Literature DB >> 23074463

Arthroscopic lavage and debridement for osteoarthritis of the knee: an evidence-based analysis.

.   

Abstract

OBJECTIVE: The purpose of this review was to determine the effectiveness and adverse effects of arthroscopic lavage and debridement, with or without lavage, in the treatment of symptoms of osteoarthritis (OA) of the knee, and to conduct an economic analysis if evidence for effectiveness can be established. QUESTIONS ASKED: Does arthroscopic lavage improve motor function and pain associated with OA of the knee?Does arthroscopic debridement improve motor function and pain associated with OA of the knee?If evidence for effectiveness can be established, what is the duration of effect?What are the adverse effects of these procedures?What are the economic considerations if evidence for effectiveness can be established? CLINICAL NEED: Osteoarthritis, the most common rheumatologic musculoskeletal disorder, affects about 10% of the Canadian adult population. Although the natural history of OA is not known, it is a degenerative condition that affects the bone cartilage in the joint. It can be diagnosed at earlier ages, particularly within the sports injuries population, though the prevalence of non-injury-related OA increases with increasing age and varies with gender, with women being twice as likely as men to be diagnosed with this condition. Thus, with an aging population, the impact of OA on the health care system is expected to be considerable. Treatments for OA of the knee include conservative or nonpharmacological therapy, like physiotherapy, weight management and exercise; and more generally, intra-articular injections, arthroscopic surgery and knee replacement surgery. Whereas knee replacement surgery is considered an end-of-line intervention, the less invasive surgical procedures of lavage or debridement may be recommended for earlier and more severe disease. Both arthroscopic lavage and debridement are generally indicated in patients with knee joint pain, with or without mechanical problems, that are refractory to medical therapy. The clinical utility of these procedures is unclear, hence, the assessment of their effectiveness in this review. LAVAGE AND DEBRIDEMENT: Arthroscopic lavage involves the visually guided introduction of saline solution into the knee joint and removal of fluid, with the intent of extracting any excess fluids and loose bodies that may be in the knee joint. Debridement, in comparison, may include the introduction of saline into the joint, in addition to the smoothening of bone surface without any further intervention (less invasive forms of debridement), or the addition of more invasive procedures such as abrasion, partial or full meniscectomy, synovectomy, or osteotomy (referred to as debridement in combination with meniscectomy or other procedures). The focus of this health technology assessment is on the effectiveness of lavage, and debridement (with or without meniscal tear resection). REVIEW STRATEGY: THE MEDICAL ADVISORY SECRETARIAT FOLLOWED ITS STANDARD PROCEDURES AND SEARCHED THESE ELECTRONIC DATABASES: Ovid MEDLINE, EMBASE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and The International Network of Agencies for Health Technology Assessment. THE KEYWORDS SEARCHED WERE: arthroscopy, debridement, lavage, wound irrigation, or curettage; arthritis, rheumatoid, osteoarthritis; osteoarthritis, knee; knee or knee joint. TIME FRAME: Only 2 previous health technology assessments were identified, one of which was an update of the other, and included 3 of 4 randomized controlled trials (RCTs) from the first report. Therefore, the search period for inclusion of studies in this assessment was January 1, 1995 to April 24, 2005. EXCLUDED WERE: case reports, comments, editorials, and letters. Identified were 335 references, including previously published health technology assessments, and 5 articles located through a manual search of references from published articles and health technology assessments. These were examined against the criteria, as described below, which resulted in the inclusion of 1 health technology assessment and its corresponding update, and 4 articles (2 RCTs and 2 level 4 studies) for arthroscopic lavage and 8 papers (2 RCTs and 6 level 4 studies) for arthroscopic debridement. INCLUSION CRITERIA: English-language articles from PubMed, EMBASE, Cochrane Systematic Reviews, and health technology assessments from January 1, 1995 onwardStudies on OA of the knee with a focus on the outcomes of motor function and painStudies of arthroscopic procedures onlyStudies in which meniscal tear resection/meniscectomy (partial or full) has been conducted in conjunction with lavage or debridement. EXCLUSION CRITERIA: Studies that focus on inflammatory OA, joint tuberculosis, septic joints, psoriatic joints (e.g., psoriatic knee joint synovitis), synovitis, chondropathy of the knee and gonarthrosis (which includes varotic gonarthrosis)Studies that focus on rheumatoid arthritisStudies that focus on meniscal tears from an acute injury (e.g., sports injury)Studies that are based on lavage or debridement for microfracture of the kneeStudies in which other surgical procedures (e.g., high tibial osteotomy, synovectomy, have been conducted in addition to lavage/debridement)Studies based on malalignment of the knee (e.g., varus/valgus arthritic conditions).Studies that compare lavage to lavage plus drug therapyStudies on procedures that are not arthroscopic (i.e., visually guided) (e.g., nonarthroscopic lavage)Studies of OA in children. INTERVENTION: Arthroscopic lavage or debridement, with or without meniscectomy, for the treatment of motor function symptoms and pain associated with OA of the knee. COMPARATORS: Studies in which there was a comparison group of either diseased or healthy subjects or one in which subjects were their own control were included. Comparisons to other treatments included placebo (or sham) arthroscopy. Sham arthroscopy involved making small incisions and manipulating the knee, without the insertion of instruments. SUMMARY OF
FINDINGS: IN EARLY OA OF THE KNEE WITH PAIN REFRACTORY TO MEDICAL TREATMENT, THERE IS LEVEL 1B EVIDENCE THAT: Arthroscopic lavage gives rise to a statistically significant, but not clinically meaningful effect in improving pain (WOMAC pain and VAS pain) up to 12 months following surgery. The effect on joint function (WOMAC function) and the primary outcome (WOMAC aggregate) was neither statistically nor clinically significant. IN MODERATE OR SEVERE OA OF THE KNEE WITH PAIN REFRACTORY TO MEDICAL TREATMENT, THERE IS: Level 1b evidence that the effect on pain and function of arthroscopic lavage (10 L saline) and debridement (with 10 L saline lavage) is not statistically significant up to 24 months following surgery.Level 2 evidence that arthroscopic debridement (with 3 L saline lavage) is effective in the control of pain in severe OA of the medial femoral condyle for up to 5 years.For debridement in combination with meniscectomy, there is level 4 evidence that the procedure, as appropriate, might be effective in earlier stages, unicompartmental disease, shorter symptom duration, sudden onset of mechanical symptoms, and preoperative full range of motion. However, as these findings are derived from very poor quality evidence, the identification of subsets of patients that may benefit from this procedure requires further testing.In patients with pain due to a meniscal tear, of the medial compartment in particular, repair of the meniscus results in better pain control at 2 years following surgery than if the pain is attributable to other causes. There is insufficient evidence to comment on the effectiveness of lateral meniscus repair on pain control.
CONCLUSIONS: Arthroscopic debridement of the knee has thus far only been found to be effective for medial compartmental OA. All other indications should be reviewed with a view to reducing arthroscopic debridement as an effective therapy. Arthroscopic lavage of the knee is not indicated for any stage of OA. There is very poor quality evidence on the effectiveness of debridement with partial meniscectomy in the case of meniscal tears in OA of the knee.

Entities:  

Year:  2005        PMID: 23074463      PMCID: PMC3382413     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN: 1915-7398


  18 in total

1.  Visually-guided irrigation in patients with early knee osteoarthritis: a multicenter randomized, controlled trial.

Authors:  K C Kalunian; L W Moreland; D J Klashman; P H Brion; A L Concoff; S Myers; R Singh; R W Ike; L L Seeger; E Rich; M L Skovron
Journal:  Osteoarthritis Cartilage       Date:  2000-11       Impact factor: 6.576

2.  Articular debridement versus washout for degeneration of the medial femoral condyle. A five-year study.

Authors:  M J Hubbard
Journal:  J Bone Joint Surg Br       Date:  1996-03

3.  Debridement arthroscopy. 10-year followup.

Authors:  B J McGinley; F D Cushner; W N Scott
Journal:  Clin Orthop Relat Res       Date:  1999-10       Impact factor: 4.176

4.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

5.  Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Authors:  W M Hopman; T Towheed; T Anastassiades; A Tenenhouse; S Poliquin; C Berger; L Joseph; J P Brown; T M Murray; J D Adachi; D A Hanley; E Papadimitropoulos
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

Review 6.  The role of debridement: through small portals.

Authors:  Henry D Clarke; W Norman Scott
Journal:  J Arthroplasty       Date:  2003-04       Impact factor: 4.757

7.  The value of knee arthroscopy in patients with severe radiological osteoarthritis.

Authors:  Michael Bohnsack; Wolfram Lipka; Oliver Rühmann; Gabriela Peters; Stefan Schmolke; Carl Joachim Wirth
Journal:  Arch Orthop Trauma Surg       Date:  2002-07-02       Impact factor: 3.067

8.  Arthroscopic debridement for the treatment of osteoarthritis of the knee: 2- and 5-year results.

Authors:  Jason Fond; Dennis Rodin; Sohail Ahmad; Robert P Nirschl
Journal:  Arthroscopy       Date:  2002-10       Impact factor: 4.772

9.  Arthroscopic debridement of the osteoarthritic knee under local anaesthesia.

Authors:  Christos Th Krystallis; John M Kirkos; Kiriakos A Papavasiliou; Panayotis A Konstantinides; Margaritis J Kyrkos; George A Kapetanos
Journal:  Acta Orthop Belg       Date:  2004-06       Impact factor: 0.500

10.  A controlled trial of arthroscopic surgery for osteoarthritis of the knee.

Authors:  J Bruce Moseley; Kimberly O'Malley; Nancy J Petersen; Terri J Menke; Baruch A Brody; David H Kuykendall; John C Hollingsworth; Carol M Ashton; Nelda P Wray
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

View more
  8 in total

1.  Diagnostic utility of fluorogenic peptide-conjugated Au nanoparticle probe corroborated by rabbit model of mild cartilage injury and panel of osteoarthritic patients.

Authors:  Zhenlong Liu; Xiaoqing Hu; Peng Yang; Jiying Zhang; Chunyan Zhou; Yingfang Ao
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Arthroscopic surgery for degenerative tears of the meniscus: a systematic review and meta-analysis.

Authors:  Moin Khan; Nathan Evaniew; Asheesh Bedi; Olufemi R Ayeni; Mohit Bhandari
Journal:  CMAJ       Date:  2014-08-25       Impact factor: 8.262

Review 3.  Treatment for cartilage injuries of the knee with a new treatment algorithm.

Authors:  Ahmet Ozmeriç; Kadir Bahadır Alemdaroğlu; Nevres Hürriyet Aydoğan
Journal:  World J Orthop       Date:  2014-11-18

Review 4.  Arthroscopic Debridement of the Knee: An Evidence Update.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-11-01

Review 5.  Advances and Prospects in Stem Cells for Cartilage Regeneration.

Authors:  Mingjie Wang; Zhiguo Yuan; Ning Ma; Chunxiang Hao; Weimin Guo; Gengyi Zou; Yu Zhang; Mingxue Chen; Shuang Gao; Jiang Peng; Aiyuan Wang; Yu Wang; Xiang Sui; Wenjing Xu; Shibi Lu; Shuyun Liu; Quanyi Guo
Journal:  Stem Cells Int       Date:  2017-01-26       Impact factor: 5.443

6.  Appropriate Use Criteria for Hyaluronic Acid in the Treatment of Knee Osteoarthritis in the United States.

Authors:  Arup K Bhadra; Roy Altman; Vinod Dasa; Karen Myrick; Jeffrey Rosen; Vijay Vad; Peter Vitanzo; Michelle Bruno; Hillary Kleiner; Caryn Just
Journal:  Cartilage       Date:  2016-08-10       Impact factor: 4.634

7.  Warm sparse-dense wave inhibits cartilage degradation in papain-induced osteoarthritis through the mitogen-activated protein kinase signaling pathway.

Authors:  Munan Lin; Yanhong Lin; Xihai Li; Wenna Liang; Shuiliang Wang; Jiansheng Liu; Xianxiang Liu; Lidian Chen; Yin Qin
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

8.  Needle-knife therapy improves the clinical symptoms of knee osteoarthritis by inhibiting the expression of inflammatory cytokines.

Authors:  Munan Lin; Xihai Li; Wenna Liang; Jianhua Liu; Jianhong Guo; Jingxiong Zheng; Xianxiang Liu
Journal:  Exp Ther Med       Date:  2014-01-30       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.